E-mail

E-mail a Wiley Online Library Link

A. D. Kirk The Cam-Path Forward American Journal of Transplantation 13

Version of Record online: 21 NOV 2012 | DOI: 10.1111/j.1600-6143.2012.04324.x

The author discusses the drug alemtuzumab as a case study in the benefits and drawbacks of off-label drug use in organ transplantation. See article by van den Hoogen et al on page 192.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field

SEARCH